Expected Impact

VetBioNet seeks to achieve the following major impacts:

  • Easy and transparent access to the consortium’s high-containment (BSL3) animal experimental facilities and laboratories, technological platforms, sample collections, reagents, and animal resources
  • Technological developments in the diagnostics and prevention and control of epizootic and zoonotic diseases and other VetBioNet-related topics (e.g. disease modeling, telemetry, and imaging)
  • Enhanced preparedness of the European community to respond to (re)emerging epizootic and zoonotic threats
  • Harmonisation of protocols and Best Practices in Europe’s major BSL3 animal experimental facilities
  • Guidelines for policy makers to adapt national and/or European biosafety regulation
  • Industrial process guidelines for the design and upgrade of BSL3 animal experimental facilities
  • Scientific review of the ethical standards and social impact of animal infectious disease research conducted in BSL3 facilities
  • Guidance on the implementation of ethical standards and Ethics Committee Best Practices
  • Enhanced usage of the consortium’s Transnational Access offer and reinforced partnership with industry stakeholders through implementation of a Dissemination Plan and a Stakeholder Platform
  • Training opportunities for young researchers (Summer courses, virtual trainings, Webinar series, E-learning platform, practical trainings) in the fields of Veterinary and Public Health
  • Development and/or standardisation of live animal or alternative infection models for high-impact epizootic or zoonotic diseases
  • Development of novel analytical tools and reagents to study host-pathogen interactions in terrestrial and aquatic livestock species
  • Development of novel imaging and telemetric tools to monitor clinical and pathological outcomes of experimental infections